SivoBiome™ Live Biotherapeutic for Resolution of Diarrhea and Prevention of Progression to Intubation in Hospitalized Covid-19 PatientsThe company sells "Visbiome" as a a "medical food intended for the dietary management of dysbiosis associated with irritable bowel syndrome (IBS), ulcerative colitis (UC), pouchitis, and hepatic encephalopathy (HE)."